Newsroom
October 23, 2017
SAN ANTONIO (Oct. 23, 2017) ― New research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans Affairs has…
October 2, 2017
UT Health San Antonio psychiatrist Steven Pliszka, M.D., is lead author on a study that shows a new formulation of an established medication for attention deficit hyperactivity disorder (ADHD) significantly…
October 2, 2017
Time-release formulation designed for children with severe ADHD symptoms upon awakening SAN ANTONIO (Oct. 2, 2017) ― UT Health San Antonio psychiatrist Steven Pliszka, M.D., is lead author on a…
September 6, 2016
…which is found at high levels in more than 80 percent of head and neck squamous cell cancers. Unfortunately, EGFR- targeted treatments have been clinically unsuccessful. Study combines two targets…
September 6, 2016
…in more than 80 percent of head and neck squamous cell cancers. Unfortunately, EGFR- targeted treatments have been clinically unsuccessful. Nameer B. Kirma, Ph.D., from the Department of Molecular Medicine…
July 16, 2015
…the National Center for Advancing Translational Sciences of the National Institutes of Health. The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center…